Due to the fact that mRNA technology allows the production of diverse vaccines and
treatments in a shorter time frame and with reduced expense compared to conventional …

Vaccines are one of the most important tools in public health and play an important role in
infectious diseases control. Owing to its precision, safe profile and flexible manufacturing …

Abstract mRNA vaccines have emerged as highly effective strategies in the prophylaxis and
treatment of diseases, thanks largely although not totally to their extraordinary performance …

Acute myeloid leukemia (AML) is a heterogeneous disease linked to a broad spectrum of
molecular alterations, and as such, long-term disease control requires multiple therapeutic …

Patients exhibit good tolerance to messenger ribonucleic acid (mRNA) vaccines, and the
choice of encoded molecules is flexible and diverse. These vaccines can be engineered to …

Intensive induction chemotherapy achieves complete remissions (CR) in> 60% of patients
with acute myeloid leukemia (AML) but overall survival (OS) is poor for relapsing patients not …

Over the past two decades, significant technological innovations have led to messenger
RNA (mRNA) becoming a promising option for developing prophylactic and therapeutic …

Messenger RNA (mRNA)‐based therapeutic strategies have shown remarkable promise in
preventing and treating a staggering range of diseases. Optimizing the structure and …

Simple Summary Immunotherapy is changing the therapeutic landscape of many
hematologic diseases. Nevertheless, in acute myeloid leukemia (AML) the anti CD33 …

Messenger RNA (mRNA) electroporation is a powerful tool for transient genetic modification
of cells. This non-viral method of genetic engineering has been widely used in …